Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Altimmune, Inc. | Chief Business Officer | Common Stock, par value $0.0001 | 14.7K | $79.3K | $5.41 | Jul 31, 2024 | Direct |
Altimmune, Inc. | Chief Business Officer | Stock Options (option to buy) | 163K | Jan 25, 2024 | Direct | ||
Altimmune, Inc. | Chief Business Officer | Restricted Stock Units | 58.4K | Jan 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Jul 31, 2024 | 1 | $4.96K | 4 | Aug 1, 2024 | Chief Business Officer |
ALT | Altimmune, Inc. | Jan 31, 2024 | 1 | $13.5K | 4 | Feb 1, 2024 | Chief Business Officer |
ALT | Altimmune, Inc. | Jan 25, 2024 | 2 | $0 | 4 | Jan 29, 2024 | Chief Business Officer |
ALT | Altimmune, Inc. | Jan 1, 2024 | 3 | -$28.2K | 4 | Jan 4, 2024 | Chief Business Officer |
ALT | Altimmune, Inc. | Jul 31, 2023 | 1 | $5.15K | 4 | Aug 2, 2023 | Chief Business Officer |
ALT | Altimmune, Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Chief Business Officer |
ALT | Altimmune, Inc. | Jan 3, 2023 | 0 | $0 | 3 | Jan 4, 2023 | Chief Business Officer |